Fate Therapeutics IncNASDAQ:FATE
- LAST PRICE3.4500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots2.7700/ 1
- Ask / Lots4.2500/ 3
- Open / Previous Close0.0000 / 3.4500
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FATE |
|---|---|---|
| 09:32 ET | 8543 | 3.48 |
| 09:34 ET | 1000 | 3.49 |
| 09:36 ET | 771 | 3.46 |
| 09:38 ET | 2843 | 3.465 |
| 09:39 ET | 995 | 3.46 |
| 09:41 ET | 1970 | 3.435 |
| 09:43 ET | 43169 | 3.475 |
| 09:45 ET | 2805 | 3.415 |
| 09:48 ET | 1700 | 3.425 |
| 09:50 ET | 1482 | 3.41 |
| 09:52 ET | 300 | 3.415 |
| 09:54 ET | 1314 | 3.42 |
| 09:56 ET | 1300 | 3.42 |
| 09:57 ET | 200 | 3.415 |
| 09:59 ET | 7887 | 3.415 |
| 10:01 ET | 1200 | 3.41 |
| 10:03 ET | 2653 | 3.37 |
| 10:06 ET | 1300 | 3.375 |
| 10:08 ET | 3948 | 3.385 |
| 10:10 ET | 11729 | 3.37 |
| 10:12 ET | 1902 | 3.38 |
| 10:14 ET | 1200 | 3.38 |
| 10:15 ET | 1843 | 3.38 |
| 10:17 ET | 6643 | 3.37 |
| 10:19 ET | 7933 | 3.375 |
| 10:21 ET | 1200 | 3.375 |
| 10:24 ET | 20658 | 3.385 |
| 10:26 ET | 3500 | 3.385 |
| 10:28 ET | 10070 | 3.385 |
| 10:30 ET | 1282 | 3.385 |
| 10:32 ET | 783 | 3.38 |
| 10:33 ET | 85424 | 3.375 |
| 10:35 ET | 11815 | 3.41 |
| 10:37 ET | 25179 | 3.405 |
| 10:39 ET | 14934 | 3.39 |
| 10:42 ET | 1064 | 3.39 |
| 10:44 ET | 5493 | 3.385 |
| 10:46 ET | 6506 | 3.385 |
| 10:48 ET | 3456 | 3.38 |
| 10:50 ET | 1829 | 3.385 |
| 10:51 ET | 6165 | 3.37 |
| 10:53 ET | 2196 | 3.385 |
| 10:55 ET | 3160 | 3.375 |
| 10:57 ET | 1464 | 3.385 |
| 11:00 ET | 900 | 3.385 |
| 11:02 ET | 6507 | 3.38 |
| 11:04 ET | 3512 | 3.37 |
| 11:06 ET | 2465 | 3.365 |
| 11:08 ET | 400 | 3.36 |
| 11:09 ET | 1341 | 3.36 |
| 11:11 ET | 700 | 3.35 |
| 11:13 ET | 520 | 3.355 |
| 11:15 ET | 8663 | 3.355 |
| 11:18 ET | 1600 | 3.3692 |
| 11:20 ET | 4134 | 3.375 |
| 11:22 ET | 1218 | 3.38 |
| 11:24 ET | 3146 | 3.39 |
| 11:26 ET | 2143 | 3.39 |
| 11:27 ET | 3107 | 3.38 |
| 11:29 ET | 21848 | 3.375 |
| 11:31 ET | 41329 | 3.41 |
| 11:33 ET | 20092 | 3.44 |
| 11:36 ET | 4231 | 3.45 |
| 11:38 ET | 6275 | 3.45 |
| 11:40 ET | 1906 | 3.45 |
| 11:42 ET | 8716 | 3.46 |
| 11:44 ET | 6721 | 3.455 |
| 11:45 ET | 805 | 3.46 |
| 11:47 ET | 600 | 3.46 |
| 11:49 ET | 5972 | 3.45 |
| 11:51 ET | 1548 | 3.455 |
| 11:54 ET | 4900 | 3.44 |
| 11:56 ET | 3648 | 3.46 |
| 11:58 ET | 1100 | 3.47 |
| 12:00 ET | 3649 | 3.455 |
| 12:02 ET | 7337 | 3.48 |
| 12:03 ET | 1451 | 3.475 |
| 12:05 ET | 600 | 3.48 |
| 12:07 ET | 3578 | 3.49 |
| 12:09 ET | 800 | 3.49 |
| 12:12 ET | 6514 | 3.49 |
| 12:14 ET | 1370 | 3.49 |
| 12:16 ET | 835 | 3.485 |
| 12:18 ET | 5409 | 3.495 |
| 12:20 ET | 5105 | 3.485 |
| 12:21 ET | 1800 | 3.495 |
| 12:23 ET | 600 | 3.5 |
| 12:25 ET | 7621 | 3.475 |
| 12:27 ET | 6870 | 3.46 |
| 12:30 ET | 4499 | 3.45 |
| 12:32 ET | 1171 | 3.455 |
| 12:34 ET | 4000 | 3.46 |
| 12:36 ET | 6021 | 3.47 |
| 12:38 ET | 700 | 3.475 |
| 12:39 ET | 500 | 3.475 |
| 12:41 ET | 3248 | 3.46 |
| 12:43 ET | 511 | 3.46 |
| 12:45 ET | 4548 | 3.465 |
| 12:48 ET | 1795 | 3.475 |
| 12:50 ET | 2310 | 3.465 |
| 12:52 ET | 200 | 3.465 |
| 12:54 ET | 600 | 3.465 |
| 12:56 ET | 4467 | 3.46 |
| 12:57 ET | 7030 | 3.455 |
| 12:59 ET | 6097 | 3.475 |
| 01:01 ET | 500 | 3.47 |
| 01:03 ET | 200 | 3.475 |
| 01:08 ET | 400 | 3.475 |
| 01:10 ET | 340 | 3.4725 |
| 01:12 ET | 631 | 3.475 |
| 01:14 ET | 600 | 3.475 |
| 01:15 ET | 4778 | 3.47 |
| 01:17 ET | 800 | 3.48 |
| 01:19 ET | 953 | 3.475 |
| 01:21 ET | 8855 | 3.485 |
| 01:24 ET | 353 | 3.49 |
| 01:26 ET | 6685 | 3.495 |
| 01:28 ET | 951 | 3.49 |
| 01:30 ET | 600 | 3.495 |
| 01:32 ET | 682 | 3.495 |
| 01:33 ET | 300 | 3.495 |
| 01:35 ET | 600 | 3.495 |
| 01:37 ET | 300 | 3.495 |
| 01:39 ET | 381 | 3.49 |
| 01:42 ET | 12549 | 3.49 |
| 01:44 ET | 200 | 3.48 |
| 01:46 ET | 10378 | 3.49 |
| 01:48 ET | 300 | 3.485 |
| 01:50 ET | 500 | 3.49 |
| 01:51 ET | 700 | 3.485 |
| 01:53 ET | 303 | 3.48 |
| 01:55 ET | 532 | 3.49 |
| 01:57 ET | 275 | 3.485 |
| 02:00 ET | 200 | 3.485 |
| 02:02 ET | 632 | 3.485 |
| 02:04 ET | 100 | 3.485 |
| 02:06 ET | 400 | 3.48 |
| 02:08 ET | 6444 | 3.475 |
| 02:09 ET | 300 | 3.47 |
| 02:11 ET | 300 | 3.47 |
| 02:13 ET | 700 | 3.475 |
| 02:15 ET | 2162 | 3.47 |
| 02:18 ET | 10531 | 3.45 |
| 02:20 ET | 1174 | 3.455 |
| 02:22 ET | 8271 | 3.465 |
| 02:24 ET | 6137 | 3.46 |
| 02:26 ET | 500 | 3.465 |
| 02:27 ET | 300 | 3.46 |
| 02:29 ET | 7059 | 3.47 |
| 02:31 ET | 3200 | 3.465 |
| 02:33 ET | 1200 | 3.465 |
| 02:36 ET | 1093 | 3.465 |
| 02:38 ET | 100 | 3.46 |
| 02:40 ET | 19377 | 3.48 |
| 02:42 ET | 8011 | 3.46 |
| 02:44 ET | 300 | 3.45 |
| 02:45 ET | 100 | 3.45 |
| 02:47 ET | 6830 | 3.445 |
| 02:49 ET | 9403 | 3.44 |
| 02:51 ET | 900 | 3.445 |
| 02:54 ET | 3277 | 3.455 |
| 02:56 ET | 3776 | 3.465 |
| 02:58 ET | 639 | 3.465 |
| 03:00 ET | 6620 | 3.47 |
| 03:02 ET | 11639 | 3.465 |
| 03:03 ET | 14793 | 3.44 |
| 03:05 ET | 650 | 3.44 |
| 03:07 ET | 4538 | 3.455 |
| 03:09 ET | 633 | 3.45 |
| 03:12 ET | 676 | 3.455 |
| 03:14 ET | 2672 | 3.45 |
| 03:16 ET | 2749 | 3.4425 |
| 03:18 ET | 200 | 3.44 |
| 03:20 ET | 5427 | 3.455 |
| 03:21 ET | 3469 | 3.44 |
| 03:23 ET | 16320 | 3.425 |
| 03:25 ET | 200 | 3.425 |
| 03:27 ET | 1291 | 3.425 |
| 03:30 ET | 7828 | 3.435 |
| 03:32 ET | 11389 | 3.425 |
| 03:34 ET | 174 | 3.425 |
| 03:36 ET | 364 | 3.425 |
| 03:38 ET | 16941 | 3.41 |
| 03:39 ET | 6405 | 3.4025 |
| 03:41 ET | 7795 | 3.41 |
| 03:43 ET | 1100 | 3.41 |
| 03:45 ET | 7059 | 3.415 |
| 03:48 ET | 1969 | 3.415 |
| 03:50 ET | 6365 | 3.405 |
| 03:52 ET | 17710 | 3.42 |
| 03:54 ET | 14916 | 3.425 |
| 03:56 ET | 15184 | 3.43 |
| 03:57 ET | 19488 | 3.44 |
| 03:59 ET | 338169 | 3.45 |
May 29, 2024
Fate Therapeutics to Present at 2024 Jefferies Global Healthcare Conference, from 4:01PM ET on Wednesday May 29, 2024 by Dow Jones
4:01PM ET on Wednesday May 29, 2024 by Dow Jones
May 16, 2024
DJ Fate Therapeutics Is Maintained at Neutral by HC Wainwright & Co., from 7:49AM ET on Thursday May 16, 2024 by Dow Jones
7:49AM ET on Thursday May 16, 2024 by Dow Jones
May 10, 2024
DJ Fate Therapeutics Is Maintained at Buy by Canaccord Genuity, from 2:48PM ET on Friday May 10, 2024 by Dow Jones
2:48PM ET on Friday May 10, 2024 by Dow JonesDJ Fate Therapeutics Is Maintained at Market Perform by BMO Capital, from 11:27AM ET on Friday May 10, 2024 by Dow Jones
11:27AM ET on Friday May 10, 2024 by Dow JonesDJ Fate Therapeutics Is Maintained at Neutral by Piper Sandler, from 9:28AM ET on Friday May 10, 2024 by Dow Jones
9:28AM ET on Friday May 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Fate Therapeutics Inc | 392.7M | -1.8x | --- |
Contineum Therapeutics Inc | 385.8M | 19.7x | --- |
ADC Therapeutics SA | 330.9M | -1.2x | --- |
Poseida Therapeutics Inc | 281.2M | -2.5x | --- |
Editas Medicine Inc | 425.2M | -2.5x | --- |
Adaptimmune Therapeutics PLC | 258.1M | -1.4x | --- |
Company Information
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders. Its proprietary induced pluripotent stem cells (iPSC) product platform combines multiplexed-engineering of human iPSCs with single-cell selection to create clonal master iPSC lines. The Company’s platform is designed to overcome numerous limitations associated with the manufacture of cell therapies using patient- or donor-sourced cells. Utilizing its proprietary iPSC product platform, it is advancing off-the-shelf, multiplexed-engineered natural killer (NK) cell and T-cell product candidates which are selectively designed, incorporate novel synthetic controls of cell function. Its pipeline of iPSC-derived, chimeric antigen receptor (CAR)-targeted NK cell and T-cell product candidates include FT819, FT522, FT576, FT825, FT819, FT522, and others.
Contact Information
- Headquarters
- 12278 Scripps Summit DriveSAN DIEGO, CA, United States 92131
- Phone
- 858-875-1803
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- William Rastetter
- President, Chief Executive Officer, Director
- John Wolchko
- Independent Vice Chairman of the Board
- John Mendlein
- Chief Financial Officer
- Edward Dulac
- General Counsel and Corporate Secretary
- Cindy Tahl
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $392.7M |
|---|---|
Revenue (TTM) | $6.5M |
Shares Outstanding | 113.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.90 |
EPS | $-1.92 |
Book Value | $3.74 |
P/E Ratio | -1.8x |
Price/Sales (TTM) | 60.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,287.85% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
